High-Intensity Ultrasound Therapy Market: Trends, Growth Drivers & Forecast 2025–2033

According to Renub Research Latest Report High-Intensity Ultrasound Therapy Market is projected to grow from USD 124.44 million in 2024 to USD 242.58 million by 2033, registering a CAGR of 7.70% from 2025 to 2033. Growth is driven by the rising adoption of non-invasive therapies, advances in ultrasound technology, and the increasing prevalence of chronic diseases and cancers.

Market Overview

High-Intensity Focused Ultrasound (HIFU) therapy is a non-invasive medical treatment that uses focused ultrasound waves to target and ablate specific tissues in the body. By generating precise thermal ablation, HIFU can treat tumors, uterine fibroids, neurological disorders, and even applications in dermatology for skin rejuvenation and tightening.

Advantages of HIFU:

Non-invasive, reducing the need for surgery and anesthesia

Precise targeting minimizes damage to surrounding tissues

Shorter recovery time and fewer complications compared to conventional surgery

Increasing applications in oncology, dermatology, and aesthetics

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Sample Report

Growth Drivers

1. Advances in Ultrasound Technology

Enhanced real-time monitoring, imaging precision, and treatment safety

Portable and cost-effective devices allow wider accessibility, even in smaller hospitals and outpatient clinics

Example: In Oct 2024, GE HealthCare introduced the Versana Premier, an advanced, versatile, and user-friendly ultrasound system.

2. Rising Demand for Non-Invasive Treatments

Patients increasingly prefer minimally invasive procedures with faster recovery times

HIFU can treat tumors, fibroids, and chronic conditions without incisions

Example: In Oct 2023, GE HealthCare partnered with Novo Nordisk to develop peripheral-focused ultrasound (PFUS) for potential metabolic therapies.

3. Increasing Prevalence of Chronic Diseases and Cancer

The rising global incidence of cancer (20 million new cases in 2022) drives demand for targeted, non-invasive therapies

HIFU provides a promising alternative for localized tumor treatment with lower risks and improved patient outcomes

Market Challenges

1. High Cost and Limited Accessibility

Advanced equipment and maintenance costs can limit adoption, especially in low-resource regions

Access remains mostly in well-funded hospitals and specialized centers

2. Lack of Skilled Professionals

HIFU requires trained operators to ensure precise targeting and safe results

Training programs and educational initiatives are essential to expand skilled workforce

Regional Insights

North America

Growth driven by advanced healthcare infrastructure and non-invasive treatment adoption

US example: ~230,125 prostate cancer cases in 2022, promoting HIFU adoption

Research & clinical trials continue to expand market opportunities

Europe

Germany leads the adoption of HIFU, supported by strong healthcare infrastructure and technology integration

Example: In June 2023, Exo and Sana Kliniken AG collaborated to expand handheld ultrasound platforms with AI support

Asia-Pacific

Rapid growth due to rising chronic disease prevalence and healthcare expansion

Example: In Feb 2023, GE Healthcare formed a joint venture with a Chinese pharmaceutical company to deliver ultrasound solutions

Latin America

Brazil is emerging as a key market for localized cancer and benign conditions treatment

Example: In July 2024, Philips Foundation and SAS Brasil launched a digital health education lab to improve access in underserved communities

Middle East & Africa

Saudi Arabia shows growth with investments in advanced medical technologies

Example: In Oct 2023, Royal Philips showcased healthcare innovations at the Global Health Exhibition

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation

By Imaging Technology:

Ultrasound HIFU Therapy

MRI HIFU Therapy

By Application:

Prostate Cancer

Uterine Fibroids

Neurological Disorders

Aesthetics

Others

By End-User:

Diagnostic Centers

Hospitals

Research Centers

Others

By Region:

North America: US, Canada

Europe: France, Germany, Italy, Spain, UK, Belgium, Netherlands, Turkey

Asia-Pacific: China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand

Latin America: Brazil, Mexico, Argentina

Middle East & Africa: Saudi Arabia, UAE, South Africa

Rest of the World

Key Players

Company Focus Areas

Koninklijke Philips N.V. HIFU and ultrasound devices

Johnson & Johnson Non-invasive therapeutic devices

Hitachi Ltd. Diagnostic imaging and HIFU technology

General Electric Ultrasound and imaging solutions

Medtronic Plc. Surgical and non-invasive therapies

Stryker Medical devices including HIFU solutions

EDAP TMS S.A Focused ultrasound and oncology

Theraclion Non-invasive therapeutic ultrasound

Coverage: Company overview, recent developments, and revenue analysis

Conclusion

The High-Intensity Ultrasound Therapy Market is set for steady growth at a CAGR of 7.70%, driven by:

Advancements in ultrasound technology

Rising preference for non-invasive treatments

Increasing prevalence of cancers and chronic diseases

Expansion of applications in aesthetics and neurology

Challenges such as equipment cost and skilled workforce limitations exist but can be mitigated with training programs, technological innovations, and strategic partnerships.

As HIFU technology continues to evolve and become more accessible, it is likely to play a key role in future non-invasive therapeutic interventions across the globe.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.